<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03588312</url>
  </required_header>
  <id_info>
    <org_study_id>P2017/Cardio/AorticPlasty</org_study_id>
    <nct_id>NCT03588312</nct_id>
  </id_info>
  <brief_title>Long Term Results in Hypoplastic Aortic Arch Repair in Neonates Using a Glutaraldehyde Treated Autologous Pericardial Patch</brief_title>
  <acronym>Aortoplasty</acronym>
  <official_title>Retrospective Analysis of Results in Children Treated by an Autologous Pericardial Patch to Repair a Hypoplastic Aortic Arch Associated to Other Congenital Heart Defects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen Fabiola Children's University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Queen Fabiola Children's University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypoplastic aortic arch is a congenital heart defect that is prejudicial for the growth of
      newborns. It is often associated to other heart defects. Different surgical techniques exist
      to address this defect, but the literature is very poor with regards to the use of an
      autologous pericardial patch. Most use extensive dissection techniques or synthetic patches.
      Here investigators report institution's original approach using the newborns own pericardium
      for what investigators believe to be an optimal correction of the hypoplasia., with preserved
      growth potential.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective analysis of an already well codified surgical intervention carried out in
      HUDERF under extra-corporeal circulation
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">September 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>30 days post surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Freedom from re-intervention</measure>
    <time_frame>Up to 18 years post initial surgery</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Congenital Hypoplasia of Aortic Arch</condition>
  <arm_group>
    <arm_group_label>simple heart defects</arm_group_label>
    <description>Newborns with hypoplastic aortic arch in simple congenital heart defects requiring aortoplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>complex heart defects.</arm_group_label>
    <description>Newborns with hypoplastic aortic arch in complex congenital heart defects requiring aortoplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Aortoplasty using autologous pericardial patch</intervention_name>
    <description>hypoplastic aortic arch repair using a glutaraldehyde treated, autologous pericardial patch.</description>
    <arm_group_label>complex heart defects.</arm_group_label>
    <arm_group_label>simple heart defects</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All newborns treated in Hopital Universitaire Des Enfants - Reine Fabiola (Brussels,
        Belgium) for a hypoplastic aortic arch and other congenital heart defects.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Newborns with a hypoplastic aortic arch undergoing a first intervention

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Louis Chebli, MD</last_name>
    <phone>0032 475262210</phone>
    <email>louis.chebli@chu-brugmann.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pierre Wauthy, MD PhD</last_name>
    <phone>0032 2 4772111</phone>
    <email>pierre.wauthy@chu-brugmann.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>HÃ´pital Universitaire Des Enfants Reine Fabiola</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Wauthy, MD PhD</last_name>
      <phone>0032 2 4772111</phone>
      <email>pierre.wauthy@chu-brugmann.be</email>
    </contact>
    <investigator>
      <last_name>Pierre Wauthy, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Louis Chebli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 4, 2018</study_first_submitted>
  <study_first_submitted_qc>July 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2018</study_first_posted>
  <last_update_submitted>July 19, 2018</last_update_submitted>
  <last_update_submitted_qc>July 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic arch hypoplasia</keyword>
  <keyword>Glutaraldehyde treated autologous pericardium</keyword>
  <keyword>Single stage repair</keyword>
  <keyword>Congenital heart defects</keyword>
  <keyword>Newborns</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

